Recent News

• 02.11.2026 - INVO Fertility Announces Patent Issuance for Modified INVOcell® Device
• 02.04.2026 - INVO Fertility Issues Shareholder Letter Highlighting Strengthened Fundamental Position and Strategic Outlook for Growth
• 01.29.2026 - INVO Fertility Enters into $7.5 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules
• 01.13.2026 - INVO Fertility to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026
• 12.30.2025 - INVO Fertility Aligns Executive Leadership Structure to Support Growth Strategy
• 12.17.2025 - INVO Fertility Signs Definitive Purchase Agreement to Acquire Indiana-Based Fertility Clinic “Family Beginnings”

Recent Filings

• 02.10.2026 - EFFECT Notice of Effectiveness
• 02.06.2026 - S-8 Securities to be offered to employees in employee benefit plans
• 02.02.2026 - S-1 General form for registration of securities under the Securities Act of 1933
• 01.30.2026 - EX-99.1 EX-99.1
• 01.30.2026 - 8-K Current report
• 01.26.2026 - 8-K Current report
• 01.21.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.13.2026 - 3 Initial statement of beneficial ownership of securities
• 01.06.2026 - EX-99.1 EX-99.1
• 01.06.2026 - 8-K Current report